Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Lawrence Kushi and Debra Ritzwoller.
Connection Strength

0.943
  1. The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016 11; 27(11):1315-1323.
    View in: PubMed
    Score: 0.145
  2. Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2017 03; 18(2):189-197.e3.
    View in: PubMed
    Score: 0.144
  3. Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer. J Oncol Pract. 2015 Sep; 11(5):356-62.
    View in: PubMed
    Score: 0.132
  4. Advanced imaging among health maintenance organization enrollees with cancer. J Oncol Pract. 2014 Jul; 10(4):231-8.
    View in: PubMed
    Score: 0.123
  5. Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experience. J Thorac Oncol. 2014 May; 9(5):692-701.
    View in: PubMed
    Score: 0.123
  6. Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network. Lung Cancer. 2012 Dec; 78(3):245-52.
    View in: PubMed
    Score: 0.110
  7. Incidence and Survival for Patients Diagnosed With Breast, Colorectal, and Lung Cancer in an Integrated System. Perm J. 2023 Sep 19; 1-7.
    View in: PubMed
    Score: 0.059
  8. Collaborating on Data, Science, and Infrastructure: The 20-Year Journey of the Cancer Research Network. EGEMS (Wash DC). 2019 Mar 29; 7(1):7.
    View in: PubMed
    Score: 0.043
  9. Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites. Ann Am Thorac Soc. 2017 Dec; 14(12):1827-1835.
    View in: PubMed
    Score: 0.039
  10. Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist. 2012; 17(3):419-27.
    View in: PubMed
    Score: 0.026

© 2024 Kaiser Permanente